# OnCo record early-onset-colorectal (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/early-onset-colorectal/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "early-onset-colorectal" ;
  schema:name "Early-onset colorectal cancer (under 50)"@en ;
  schema:alternateName "Young-onset colorectal cancer"@en, "Colorectal cancer in adults under 50"@en, "Early-age-onset colorectal cancer"@en, "Bowel cancer in young adults"@en ;
  schema:description "Bowel cancer is rising in people under 50, for reasons that are still not understood, and it is usually found late because neither patients nor doctors expect it. Treatment is the same as in older adults and works as well stage for stage; the changes are earlier screening, genetic testing for everyone diagnosed young, and attention to fertility, work and family."@en ;
  schema:url <https://onco.cc/cancers/early-onset-colorectal/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Colorectal_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Colorectal_cancer>, <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1428> ;
  onco:tag "subtype-page" ;
  onco:technologies <https://onco.cc/technologies/colorectal-screening/>, <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/technologies/exercise-oncology/>, <https://onco.cc/technologies/ai-endoscopy-detection/> ;
  onco:targets <https://onco.cc/targets/kras/>, <https://onco.cc/targets/braf/>, <https://onco.cc/targets/her2/>, <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/shield/>, <https://onco.cc/drugs/cologuard/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/capox/> ;
  onco:pathways <https://onco.cc/pathways/colorectal-cancer-signalling/> ;
  onco:terms <https://onco.cc/terms/lynch-syndrome/>, <https://onco.cc/terms/msi/>, <https://onco.cc/terms/fit-test/>, <https://onco.cc/terms/colonoscopy/>, <https://onco.cc/terms/sidedness/> ;
  onco:trials <https://onco.cc/trials/challenge/>, <https://onco.cc/trials/nordicc/>, <https://onco.cc/trials/eclipse-shield/> ;
  onco:people <https://onco.cc/people/chadwick-boseman/>, <https://onco.cc/people/michael-bretthauer/> ;
  onco:pipeline <https://onco.cc/ideas/idea-prev-prs-screening-start-age/>, <https://onco.cc/ideas/idea-prev-reflex-germline-testing/>, <https://onco.cc/drugs/shield/>, <https://onco.cc/technologies/colorectal-screening/>, <https://onco.cc/ideas/idea-prev-blood-crc-test-for-non-responders/> ;
  onco:standardOfCare <https://onco.cc/technologies/colorectal-screening/>, <https://onco.cc/terms/fit-test/>, <https://onco.cc/terms/colonoscopy/>, <https://onco.cc/drugs/shield/>, <https://onco.cc/drugs/cologuard/>, <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/terms/lynch-syndrome/>, <https://onco.cc/terms/msi/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/terms/total-neoadjuvant-therapy/>, <https://onco.cc/terms/organ-preservation/>, <https://onco.cc/trials/rapido/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/encorafenib/>, <https://onco.cc/drugs/tucatinib/>, <https://onco.cc/drugs/sotorasib/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/technologies/exercise-oncology/>, <https://onco.cc/trials/challenge/> .